Right ventricular dysfunction in preclinical models of type I and type II diabetes
Canadian Journal of Physiology and Pharmacology · 2025
DOI: 10.1139/cjpp-2024-0195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2025. Verfasst von Sydney M Polson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Kinesiology & Health, University of Wyoming, Laramie, WY, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Ventricular Dysfunction, Right, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: NIDDK Diabetic Complications Consortium, National Institute of General Medical Sciences, National Institute on Aging.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetic cardiomyopathy (DCM) is a growing clinical entity and major health burden characterized by comorbid diabetes mellitus and heart failure. DCM has been commonly associated with impaired function of the left ventricle (LV); however, DCM likely also occurs in the right ventricle (RV) which has distinct physiology and pathophysiology from the LV. RV dysfunction is the strongest determinant of mortality in several clinical contexts yet remains poorly studied in diabetes. We investigated RV-specific pathophysiology using two models of diabetes—a well-characterized type 2 diabetes (T2DM) model of high-fat diet and low-dose streptozotocin (STZ) in the mouse and a large animal model of type I diabetes in domestic pigs rendered diabetic with STZ. RV global and systolic function deteriorated with diabetes, alongside hypertrophic and fibrotic remodeling. We report evidence of impaired RV insulin sensitivity, dysregulated RV metabolic gene expression, and impaired mitochondrial dynamics. Importantly, while some of these outcomes were similar to those widely reported in the LV, others were not, such as unchanged antioxidant gene expression and regulators of fatty acid uptake. Importantly, these RV-specific changes occurred in both male and female T2DM mice, together emphasizing the importance of distinguishing the RV from the LV when studying DCM and begging the consideration of RV-specific therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Kinesiology & Health, University of Wyoming, Laramie, WY, USA.
- WWAMI Medical Education, University of Washington, Seattle, WA, USA.
- School of Pharmacy, University of Wyoming, Laramie, WY, USA.
ORCID-Profile: Danielle R Bruns
Förderung
- NIDDK Diabetic Complications Consortium
- National Institute of General Medical Sciences
- National Institute on Aging
- National Institutes of Health
- University of Wyoming College of Health Sciences
Zitieren
APA
Polson, S., Thornburg, J., McNair, B., Cook, C., Straight, E., Fontana, K., Hoopes, C., Nair, S., & Bruns, D. R. (2025). Right ventricular dysfunction in preclinical models of type I and type II diabetes. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2024-0195
Vancouver
Polson S, Thornburg J, McNair B, Cook C, Straight E, Fontana K, et al. Right ventricular dysfunction in preclinical models of type I and type II diabetes. Canadian Journal of Physiology and Pharmacology. 2025. doi:10.1139/cjpp-2024-0195
BibTeX
@article{Polson2025,
author = {Polson, Sydney M and Thornburg, Joshua P and McNair, Benjamin D and Cook, Christian Z and Straight, Elizabeth A and Fontana, Kevin C and Hoopes, Caleb R and Nair, Sreejayan and Bruns, Danielle R},
title = {Right ventricular dysfunction in preclinical models of type I and type II diabetes},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2025},
doi = {10.1139/cjpp-2024-0195}
}
EUVIMED